Lecture 7- Special populations Flashcards
Special populations
Drugs don’t work the same in every person
People respond in different ways
- disease
- pregnancy
- age
- sex
Most of our understanding of special populations comes from
Pharmacokinetics
- how the body changes the drug
- changes in ADME
We know very little about changes due to pharmacodynamics
- drug response caused by drug-receptor interactions
Disease: special populations
- Many diseases alter drug exposure and response
- Most disease is the result of Hepatic (liver) and renal (kidney) impairment
- Effect of hepatic and renal impairments on pharmacokinetics are multifactorial
- Organ size
- Tissue composition
- Blood flow
- Enzyme activities
- Transport activities
- Protein binding
Chronic kidney disease
- Kidney effectiveness= GFR
- how well they are filtering per min
- Using GFR as a metric -> putting people into different classes of kidney failure
Ganciclovir
- anti-viral used to treat cytomegalovirus (CMV)
- eliminated primarily through kidney excretion
- creatine clearance is used as a proxy for GFR
- *renal impairment can slow drug elimination*
Example of ACE inhibitors being renoprotective
- ACE inhibitors is renoprotective in diabetes
- ACE inhibitors lower bp
- in diabetes, there is higher afferent flow
- leads to higher pressure in glomerulus
- ACE inhibitors block Ang 2, leads to dilation of efferent
- balances out the pressure
Example of ACE inhibitors in renal failure
- Renal failure: have reduce afferent flow
- opening it up even more, having no pressure coming through capillaries
- kidneys lose ability to filter
Relationship between Hepatic impairment and metabolism
- the amount of drug removed by the liver is dependent on hepatic blood flow
- Hepatic impairment -> decreased blood flow -> decreased metabolism
- As hepatic function decreases, all the different CYP enzymes decrease at different rates
- some drugs metabolized by diff CYPs,
- Do get decreased drug metabolism with impairment of the liver
Liver impairement and oral drug bio-availability
- The magnitude of change in drug exposure due to the effect of hepatic impairment on oral bioavailability depends on the extent of hepatic extraction
- Some drugs are metabolized more by the liver by first pass than others
Cirrhosis
- complication of liver disease
- commonly caused by:
- long term alcohol abuse
- viral hepatitis B and C
- loss of liver cells and permanent scarring
- liver function greatly decreased
Chlormethiazole
- has a high hepatic extraction ratio
- used to treat and prevent symptoms of acute alcohol withdrawal
- alcohol use can lead to overdose
Pregnancy
profound physiological change
- increased GFR
- altered hepatic metabolism
- GI motility slows
- changes in drug volume of distribution
- many other changes: respiratory rate, bp, plasma albumin, heat rate, etc
All of these changes affect pharmacokinetics
ex: amocillin concentrations are lower during pregnancy than post-partum
* due to increased GFR
Many drugs can pass through the placental barrier
teratogenic
- agent that can disturb the development of an embryo or fetus
FDA safety categories